30-Day Unplanned Readmit Rate Low but Costly in Head, Neck Sx

This article originally appeared here.
Share this content:
30-Day Unplanned Readmit Rate Low but Costly in Head, Neck Sx
30-Day Unplanned Readmit Rate Low but Costly in Head, Neck Sx

WEDNESDAY, April 22, 2015 (HealthDay News) -- For patients undergoing head and neck surgery, 30-day unplanned readmission rates are low, but costly, according to a review published online March 9 in Head & Neck.

Peter T. Dziegielewski, M.D., from The Ohio State University Wexner Medical Center in Columbus, and colleagues conducted a retrospective review involving 607 patients undergoing 660 head and neck operations. The authors sought to determine the rate, predictors of, and costs of 30-day unplanned readmissions. Risk factors for 30-day unplanned readmissions were identified in logistic regression analyses.

The researchers found that 7.3 percent of cases had 30-day unplanned readmission. Coronary artery disease (odds ratio [OR], 2.8), chronic renal failure (OR, 3.56), not attending preoperative clinic (OR, 2.74), length of stay greater than five days (OR, 3.19), and presence of a gastrostomy tube (OR, 2.75) were identified as significant independent risk factors for readmissions. The total cost of 30-day unplanned readmissions was $1.68 million.

"Thirty-day unplanned readmissions in head and neck surgery patients can be low, but costly," the authors write. "Identifying patients at risk for 30-day unplanned readmissions will help develop preventative strategies."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

Congress Approves Bill Expanding Private Care for VA Patients

Congress Approves Bill Expanding Private Care for VA ...

New bill would open up access to private doctors for veterans

AAP Recommending Injectable Flu Shot for 2018-19 Flu Season

AAP Recommending Injectable Flu Shot for 2018-19 Flu ...

Children should receive injectable vaccine, which has been shown to be more consistently effective

Neurologists Identify New Type of Vertigo

Neurologists Identify New Type of Vertigo

Long-term prognosis favorable, with improvement of symptoms in more than half of patients